OP was slightly more bullish than Ron in its recent report and ended up with a Buy recommendation with a target price of €18:
“Pihlajalinna’s quarter was more challenging than expected due to lost occupational health customers, low purchases from wellbeing services counties, and significantly lower morbidity. On the other hand, the profitability of public services was at a record level, and the company’s sales pipeline looks promising for next year. We raised our forecasts for next year, which is why our target price is adjusted to 18.00 euros (prev. 17.70). Following the share price decline in recent days, we consider the return potential over a one-year horizon to be very good. We raise the recommendation to BUY (prev. ADD).”